N-myc over-expression downregulates alpha3beta1 integrin expression in human Saos-2 osteosarcoma cells

Area of Science:

• Cell Biology
• Molecular Oncology
• Biochemistry

Background:

• Integrin receptors mediate cell adhesion to the extracellular matrix, and their alterations are common in various cancers.
• Reduced integrin subunit expression is observed in neuroblastoma cell lines overexpressing the N-myc oncogene.
• N-myc transfection in neuroblastoma cells leads to decreased alpha2, alpha3, and beta1 integrin subunits and cell rounding.

Purpose of the Study:

• To investigate whether N-myc-mediated integrin downregulation is cell-type specific.
• To evaluate the effect of N-myc transfection on integrin expression in human osteosarcoma cells.

Main Methods:

• Transfection of human N-myc cDNA into Saos-2 human osteosarcoma cells.
• Isolation and analysis of N-myc-expressing cell lines.
• Evaluation of integrin subunit protein and mRNA levels.
• Assessment of cell morphology and integrin complex formation.

Main Results:

• N-myc-expressing osteosarcoma cells showed reduced beta1 integrin subunit protein and altered cell morphology, similar to neuroblastoma cells.
• Osteosarcoma-derived N-myc transfectants exhibited minimal alpha3beta1 integrin complexes.
• Reduced alpha3 integrin subunit levels occurred at the mRNA level, with potential post-transcriptional involvement for beta1.

Conclusions:

• N-myc downregulates integrin expression in a cell-type non-specific manner, affecting both neural and connective tissue cells.
• The N-myc-dependent process impacts cell adhesion and morphology through alterations in integrin extracellular matrix receptors.
• These findings confirm previous studies and extend the understanding of N-myc's role in integrin regulation across different cell types.